Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of hepatitis B immunoglobulin prophylaxis after liver transplantation for HBV-related liver disease
2008-007027-11Phase 4Terminated
- Sponsor
- Cardarelli Hospital
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of hepatitis B immune globulin in hepatitis B (HBV) and Hepatitis B-related liver disease, sponsored by Cardarelli Hospital. Primary endpoints: Maintenance of protective anti-HBs antibody titer and Reduction in HBIG monthly dose requirement. Started Dec 2008; status: terminated.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)Hepatitis B-related liver disease
Beyond the preview
Go deeper on 2008-007027-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007027-11.